Smith-Van Vurst Andrewinsider trades
In SEC Form 4 filings, Smith-Van Vurst Andrew is listed as Chief Operating Officer of BioStem Technologies, Inc. (BSEM). Smith-Van Vurst Andrew reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 9.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| BSEMBioStem Technologies, Inc. | Chief Operating Officer | 6 | Oct 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| BSEMBioStem Technologies, Inc. | Oct 7 | Oct 9 | M | 250,000 | $2.00 | $500,000 | 1,789,809 | No | Form 4 |
| BSEMBioStem Technologies, Inc. | Oct 7 | Oct 9 | M · derivative | 250,000 | $2.00 | $500,000 | 2,000,000 | No | Form 4 |
| BSEMBioStem Technologies, Inc. | Sep 17 | Sep 17 | M | 9,574 | $0.00 | $0 | 1,539,809 | No | Form 4 |
| BSEMBioStem Technologies, Inc. | Sep 17 | Sep 17 | M · derivative | 9,574 | $0.00 | $0 | 57,442 | No | Form 4 |
| BSEMBioStem Technologies, Inc. | Sep 15 | Sep 17 | M | 7,622 | $0.00 | $0 | 1,530,235 | No | Form 4 |
| BSEMBioStem Technologies, Inc. | Sep 15 | Sep 17 | M · derivative | 7,622 | $0.00 | $0 | 30,487 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.